OSE Immunotherapeutics SA Sustainability Reports
OSE Immunotherapeutics is a biotechnology company focused on developing first-in-class therapies in immuno-oncology and immuno-inflammation.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 969500HIUWVGY6NZSM05
FIGI: BBG008891XG3
13 reports from 2019 to 2025
- OSE Immunotherapeutics SA 2025 Universal Registration Document
- OSE Immunotherapeutics SA 2025 Universal Registration Document Including the Annual Financial Report
- OSE Immunotherapeutics SA 2023 Universal Registration Document Including Annual Financial Report
- OSE Immunotherapeutics SA 2023 Professional Equality Index
- OSE Immunotherapeutics SA 2023 Universal Registration Document Including the Annual Financial Report
